Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial - Malmström, A; Grønberg, B H; Marosi, C; Nordic Clinical Brain Tumour Study Group (NCBTSG) (Lancet Oncol, 2012)